EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 40 / No 4 (Avril 2024) Med Sci (Paris), 40 4 (2024) 361-368 References
Open Access
Issue
Med Sci (Paris)
Volume 40, Number 4, Avril 2024
Page(s) 361 - 368
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2024039
Published online 23 April 2024
  1. Baracos VE, Martin L, Korc M, et al. Cancer-associated cachexia. Nat Rev Disease primers 2018 ; 4 : 17105. [CrossRef] [Google Scholar]
  2. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011 ; 12 : 489–495. [CrossRef] [PubMed] [Google Scholar]
  3. Ferrer M, Anthony TG, Ayres JS, et al. Cachexia: A systemic consequence of progressive, unresolved disease. Cell 2023; 186 : 1824–45. [CrossRef] [PubMed] [Google Scholar]
  4. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell metab 2012 ; 16 : 153–166. [CrossRef] [PubMed] [Google Scholar]
  5. Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 2016 ; 5 : e200. [CrossRef] [PubMed] [Google Scholar]
  6. Ferrara M, Samaden M, Ruggieri E, Venereau E. Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene. Front Cell Dev Biol 2022; 10 : 960341. [CrossRef] [PubMed] [Google Scholar]
  7. Wyart E, Bindels LB, Mina E, et al. Cachexia, a Systemic Disease beyond Muscle Atrophy. Int J Mol Sci 2020; 21 : 8592. [CrossRef] [PubMed] [Google Scholar]
  8. Fonseca G, Farkas J, Dora E, et al. Cancer Cachexia and Related Metabolic Dysfunction. Int J Mol Sci 2020; 21 : 2321. [CrossRef] [PubMed] [Google Scholar]
  9. Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep 2019 ; 20. [Google Scholar]
  10. Fang R, Yan L, Liao Z. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Front Oncol 2023; 13 : 1123567. [Google Scholar]
  11. Setiawan T, Sari IN, Wijaya YT, et al. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol 2023; 16 : 54. [CrossRef] [PubMed] [Google Scholar]
  12. Talbert EE, Cuitino MC, Ladner KJ, et al. Modeling Human Cancer-induced Cachexia. Cell Rep 2019 ; 28 : 1612–22.e4. [Google Scholar]
  13. Paval DR, Patton R, McDonald J, et al. A systematic review examining the relationship between cytokines and cachexia in incurable cancer. J Cachexia Sarcopenia Muscle 2022; 13 : 824–38. [CrossRef] [PubMed] [Google Scholar]
  14. Kadakia KC, Hamilton-Reeves JM, Baracos VE. Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach. Am Soc Clin Oncol Educ Book 2023; 43 : e389942. [CrossRef] [PubMed] [Google Scholar]
  15. Argiles JM, Stemmler B, Lopez-Soriano FJ, Busquets S. Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol 2018 ; 15 : 9–20. [Google Scholar]
  16. Martin A, Gallot YS, Freyssenet D. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies. J Cachexia Sarcopenia Muscle 2023; 14 : 1150–67. [CrossRef] [PubMed] [Google Scholar]
  17. Flint TR, Janowitz T, Connell CM, et al. Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity. Cell metab 2016 ; 24 : 672–684. [CrossRef] [PubMed] [Google Scholar]
  18. Daas SI, Rizeq BR, Nasrallah GK. Adipose tissue dysfunction in cancer cachexia. J Cell Physiol 2018 ; 234 : 13–22. [Google Scholar]
  19. Weber BZC, Arabaci DH, Kir S. Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia. Front Oncol 2022; 12 : 848394. [Google Scholar]
  20. Molfino A, Imbimbo G, Muscaritoli M. Metabolic and histomorphological changes of adipose tissue in cachexia. Curr Opin Clin Nutr Metab Care 2023; 26 : 235–42. [CrossRef] [PubMed] [Google Scholar]
  21. Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell metab 2014 ; 20 : 433–447. [CrossRef] [PubMed] [Google Scholar]
  22. Tsoli M, Moore M, Burg D, et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer res 2012 ; 72 : 4372–4382. [CrossRef] [PubMed] [Google Scholar]
  23. Das SK, Eder S, Schauer S, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 2011 ; 333 : 233–238. [CrossRef] [PubMed] [Google Scholar]
  24. Engineer DR, Garcia JM. Leptin in anorexia and cachexia syndrome. Int J Pept 2012 ; 2012 : 287457. [CrossRef] [Google Scholar]
  25. Mannelli M, Gamberi T, Magherini F, Fiaschi T. The Adipokines in Cancer Cachexia. Int J Mol Sci 2020; 21. [PubMed] [Google Scholar]
  26. Panebianco C, Villani A, Potenza A, et al. Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options. International journal of molecular sciences 2023; 24. [PubMed] [Google Scholar]
  27. McDonald J, Sayers J, Anker SD, et al. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle 2023; 14 : 1932–48. [CrossRef] [PubMed] [Google Scholar]
  28. Sayers J, Skipworth RJ, Laird BJ. Cancer cachexia - adopting a systems wide approach. Curr Opin Clin Nutr Metab Care 2023; 26 : 393–8. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.